Page last updated: 2024-11-10

cx717

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CX717: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3323368
CHEMBL ID4791762
SCHEMBL ID243542
MeSH IDM0537916

Synonyms (23)

Synonym
OPREA1_513346
cx717
2,1,3-benzoxadiazol-5-yl(morpholin-4-yl)methanone
867276-98-0
cx 717
cx-717
cx 717 (pharmaceutical)
SCHEMBL243542
CS-0256234
DB05047
CHEMBL4791762
benzo[c][1,2,5]oxadiazol-5-yl(morpholino)methanone
BS-47001
unii-7i12yta3qm
211735-82-9
morpholine, 4-(2,1,3-benzoxadiazol-5-ylcarbonyl)-
2,1,3-benzoxadiazol-5-yl-4-morpholinylmethanone
7I12YTA3QM ,
STARBLD0003244
EX-A6414
DTXSID301241632
Z2228297363
AKOS040758937

Research Excerpts

Overview

CX717 is a positive allosteric modulator of the AMPA receptor. It has shown efficacy in rodent and primate cognition models.

ExcerptReferenceRelevance
"CX717 is a positive allosteric modulator of the AMPA receptor that has shown efficacy in rodent and primate cognition models."( Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep.
Arbon, EL; Boyle, J; Dijk, DJ; James, LM; Johnsen, S; Stanley, N; Wright, N, 2012
)
1.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.76)29.6817
2010's10 (58.82)24.3611
2020's5 (29.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.72 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index95.27 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (11.76%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]